BMC Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2242072, encodeId=3adc22420e28d, content=10月份投稿，11月审稿意见大修，12月返修，目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b482175865, createdName=12060c54m83(暂无昵称), createdTime=Thu Dec 12 16:21:06 CST 2024, time=2024-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2243718, encodeId=5adf2243e182c, content=偏重的研究方向：流行病学 经验分享：今年12月4日投稿BMC medicine，投稿当天到现在12月20日还是with editor状况，是我太急了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b9c6398102, createdName=ms3000001290442795, createdTime=Fri Dec 20 11:08:01 CST 2024, time=2024-12-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2239220, encodeId=3100223922047, content=第二次外审意见回来后在编辑那里1个多月了也没信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Nov 26 10:28:34 CST 2024, time=2024-11-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2239217, encodeId=b116223921ed0, content=审稿速度:6.0 经验分享：7.25提交投稿，9.13审稿意见回来要求大修，10.3提交修订版，10.25系统显示编辑已收到全部审稿意见，然而过了一个月多没消息了，发了催稿信也没回复，不知道编辑什么决定~~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Nov 26 10:17:56 CST 2024, time=2024-11-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2240967, encodeId=9ca3224096e4d, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审2个月，半个月回复，目前分配编辑状态半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b482175865, createdName=12060c54m83(暂无昵称), createdTime=Thu Dec 05 15:44:35 CST 2024, time=2024-12-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2239680, encodeId=4f5c22396803b, content=对这个期刊大无语，提了一个比较新颖的观点，三个审稿人两轮审稿前后六个月时间，最后审稿人没问题了，编辑不认同我文章提出的主要观点，给拒了，你早干嘛去了啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4579315575, createdName=ms2000001369168749, createdTime=Thu Nov 28 09:47:05 CST 2024, time=2024-11-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2240722, encodeId=a9962240e2254, content=投稿命中率:25.0 经验分享：投稿第七天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c8f9557053, createdName=ms2000001959141443, createdTime=Tue Dec 03 23:49:38 CST 2024, time=2024-12-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200944, encodeId=4a382200944df, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：拒稿挺干脆的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96539239417, createdName=ms3000001172034074, createdTime=Sun Apr 28 21:31:39 CST 2024, time=2024-04-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155573, encodeId=79fc21555e3e3, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：阿尔茨海默;脑血管病 经验分享：BMC Medicine，BMC家旗下相当好的综合医学期刊，当前(指截止2023.9.1) Impact Factor 9.3，但是审稿速度相当堪忧，官网提供的宣称指出“62 days submission to first editorial decision for all manuscripts (Median)，130 days submission to accept (Median)”，即中位数62天才能给出第一次送外审后的编辑部决定，中位数130天才能正式接受发表。但实际上其官网的Transparent Peer Review指出大部分稿件往往需要花上近半年的时间才可以最终发表，并且审稿人中途退出以及更换审稿人的现象较为常见，审稿人以及编辑部的意见也往往较为犀利，Submission多需要经过三四次的Revision才会被最终Accept，综合评价为投递需要经过慎重考虑，Desk Reject那便还好，如果你的文章时效性较强，那么一旦被送出外审后进入漫长的Review恐会影响你文章后续的时效性价值，甚至有被其他课题研究人员于某些****杂志抢发类似文章的风险, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Fri Sep 01 09:54:24 CST 2023, time=2023-09-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191029, encodeId=68a12191029fd, content=1-6 投稿 1-6 editor assigned 1-11 reviewers assigned 2-27 under review 3-1 reviewers assigned 3-3 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a18637611, createdName=ms3000001077948666, createdTime=Mon Mar 04 19:27:41 CST 2024, time=2024-03-04, status=1, ipAttribution=北京)]

2024-12-12 12060c54m83(暂无昵称) 来自四川省

10月份投稿，11月审稿意见大修，12月返修，目前等待中

22 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2242072, encodeId=3adc22420e28d, content=10月份投稿，11月审稿意见大修，12月返修，目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b482175865, createdName=12060c54m83(暂无昵称), createdTime=Thu Dec 12 16:21:06 CST 2024, time=2024-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2243718, encodeId=5adf2243e182c, content=偏重的研究方向：流行病学 经验分享：今年12月4日投稿BMC medicine，投稿当天到现在12月20日还是with editor状况，是我太急了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b9c6398102, createdName=ms3000001290442795, createdTime=Fri Dec 20 11:08:01 CST 2024, time=2024-12-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2239220, encodeId=3100223922047, content=第二次外审意见回来后在编辑那里1个多月了也没信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Nov 26 10:28:34 CST 2024, time=2024-11-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2239217, encodeId=b116223921ed0, content=审稿速度:6.0 经验分享：7.25提交投稿，9.13审稿意见回来要求大修，10.3提交修订版，10.25系统显示编辑已收到全部审稿意见，然而过了一个月多没消息了，发了催稿信也没回复，不知道编辑什么决定~~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Nov 26 10:17:56 CST 2024, time=2024-11-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2240967, encodeId=9ca3224096e4d, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审2个月，半个月回复，目前分配编辑状态半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b482175865, createdName=12060c54m83(暂无昵称), createdTime=Thu Dec 05 15:44:35 CST 2024, time=2024-12-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2239680, encodeId=4f5c22396803b, content=对这个期刊大无语，提了一个比较新颖的观点，三个审稿人两轮审稿前后六个月时间，最后审稿人没问题了，编辑不认同我文章提出的主要观点，给拒了，你早干嘛去了啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4579315575, createdName=ms2000001369168749, createdTime=Thu Nov 28 09:47:05 CST 2024, time=2024-11-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2240722, encodeId=a9962240e2254, content=投稿命中率:25.0 经验分享：投稿第七天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c8f9557053, createdName=ms2000001959141443, createdTime=Tue Dec 03 23:49:38 CST 2024, time=2024-12-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200944, encodeId=4a382200944df, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：拒稿挺干脆的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96539239417, createdName=ms3000001172034074, createdTime=Sun Apr 28 21:31:39 CST 2024, time=2024-04-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155573, encodeId=79fc21555e3e3, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：阿尔茨海默;脑血管病 经验分享：BMC Medicine，BMC家旗下相当好的综合医学期刊，当前(指截止2023.9.1) Impact Factor 9.3，但是审稿速度相当堪忧，官网提供的宣称指出“62 days submission to first editorial decision for all manuscripts (Median)，130 days submission to accept (Median)”，即中位数62天才能给出第一次送外审后的编辑部决定，中位数130天才能正式接受发表。但实际上其官网的Transparent Peer Review指出大部分稿件往往需要花上近半年的时间才可以最终发表，并且审稿人中途退出以及更换审稿人的现象较为常见，审稿人以及编辑部的意见也往往较为犀利，Submission多需要经过三四次的Revision才会被最终Accept，综合评价为投递需要经过慎重考虑，Desk Reject那便还好，如果你的文章时效性较强，那么一旦被送出外审后进入漫长的Review恐会影响你文章后续的时效性价值，甚至有被其他课题研究人员于某些****杂志抢发类似文章的风险, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Fri Sep 01 09:54:24 CST 2023, time=2023-09-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191029, encodeId=68a12191029fd, content=1-6 投稿 1-6 editor assigned 1-11 reviewers assigned 2-27 under review 3-1 reviewers assigned 3-3 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a18637611, createdName=ms3000001077948666, createdTime=Mon Mar 04 19:27:41 CST 2024, time=2024-03-04, status=1, ipAttribution=北京)]

2024-12-20 ms3000001290442795 来自广西

偏重的研究方向：流行病学
经验分享：今年12月4日投稿BMC medicine，投稿当天到现在12月20日还是with editor状况，是我太急了吗？

14 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2242072, encodeId=3adc22420e28d, content=10月份投稿，11月审稿意见大修，12月返修，目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b482175865, createdName=12060c54m83(暂无昵称), createdTime=Thu Dec 12 16:21:06 CST 2024, time=2024-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2243718, encodeId=5adf2243e182c, content=偏重的研究方向：流行病学 经验分享：今年12月4日投稿BMC medicine，投稿当天到现在12月20日还是with editor状况，是我太急了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b9c6398102, createdName=ms3000001290442795, createdTime=Fri Dec 20 11:08:01 CST 2024, time=2024-12-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2239220, encodeId=3100223922047, content=第二次外审意见回来后在编辑那里1个多月了也没信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Nov 26 10:28:34 CST 2024, time=2024-11-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2239217, encodeId=b116223921ed0, content=审稿速度:6.0 经验分享：7.25提交投稿，9.13审稿意见回来要求大修，10.3提交修订版，10.25系统显示编辑已收到全部审稿意见，然而过了一个月多没消息了，发了催稿信也没回复，不知道编辑什么决定~~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Nov 26 10:17:56 CST 2024, time=2024-11-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2240967, encodeId=9ca3224096e4d, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审2个月，半个月回复，目前分配编辑状态半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b482175865, createdName=12060c54m83(暂无昵称), createdTime=Thu Dec 05 15:44:35 CST 2024, time=2024-12-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2239680, encodeId=4f5c22396803b, content=对这个期刊大无语，提了一个比较新颖的观点，三个审稿人两轮审稿前后六个月时间，最后审稿人没问题了，编辑不认同我文章提出的主要观点，给拒了，你早干嘛去了啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4579315575, createdName=ms2000001369168749, createdTime=Thu Nov 28 09:47:05 CST 2024, time=2024-11-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2240722, encodeId=a9962240e2254, content=投稿命中率:25.0 经验分享：投稿第七天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c8f9557053, createdName=ms2000001959141443, createdTime=Tue Dec 03 23:49:38 CST 2024, time=2024-12-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200944, encodeId=4a382200944df, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：拒稿挺干脆的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96539239417, createdName=ms3000001172034074, createdTime=Sun Apr 28 21:31:39 CST 2024, time=2024-04-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155573, encodeId=79fc21555e3e3, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：阿尔茨海默;脑血管病 经验分享：BMC Medicine，BMC家旗下相当好的综合医学期刊，当前(指截止2023.9.1) Impact Factor 9.3，但是审稿速度相当堪忧，官网提供的宣称指出“62 days submission to first editorial decision for all manuscripts (Median)，130 days submission to accept (Median)”，即中位数62天才能给出第一次送外审后的编辑部决定，中位数130天才能正式接受发表。但实际上其官网的Transparent Peer Review指出大部分稿件往往需要花上近半年的时间才可以最终发表，并且审稿人中途退出以及更换审稿人的现象较为常见，审稿人以及编辑部的意见也往往较为犀利，Submission多需要经过三四次的Revision才会被最终Accept，综合评价为投递需要经过慎重考虑，Desk Reject那便还好，如果你的文章时效性较强，那么一旦被送出外审后进入漫长的Review恐会影响你文章后续的时效性价值，甚至有被其他课题研究人员于某些****杂志抢发类似文章的风险, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Fri Sep 01 09:54:24 CST 2023, time=2023-09-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191029, encodeId=68a12191029fd, content=1-6 投稿 1-6 editor assigned 1-11 reviewers assigned 2-27 under review 3-1 reviewers assigned 3-3 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a18637611, createdName=ms3000001077948666, createdTime=Mon Mar 04 19:27:41 CST 2024, time=2024-03-04, status=1, ipAttribution=北京)]

2024-11-26 ms9000001244919142 来自广东省

第二次外审意见回来后在编辑那里1个多月了也没信

0 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2242072, encodeId=3adc22420e28d, content=10月份投稿，11月审稿意见大修，12月返修，目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b482175865, createdName=12060c54m83(暂无昵称), createdTime=Thu Dec 12 16:21:06 CST 2024, time=2024-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2243718, encodeId=5adf2243e182c, content=偏重的研究方向：流行病学 经验分享：今年12月4日投稿BMC medicine，投稿当天到现在12月20日还是with editor状况，是我太急了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b9c6398102, createdName=ms3000001290442795, createdTime=Fri Dec 20 11:08:01 CST 2024, time=2024-12-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2239220, encodeId=3100223922047, content=第二次外审意见回来后在编辑那里1个多月了也没信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Nov 26 10:28:34 CST 2024, time=2024-11-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2239217, encodeId=b116223921ed0, content=审稿速度:6.0 经验分享：7.25提交投稿，9.13审稿意见回来要求大修，10.3提交修订版，10.25系统显示编辑已收到全部审稿意见，然而过了一个月多没消息了，发了催稿信也没回复，不知道编辑什么决定~~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Nov 26 10:17:56 CST 2024, time=2024-11-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2240967, encodeId=9ca3224096e4d, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审2个月，半个月回复，目前分配编辑状态半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b482175865, createdName=12060c54m83(暂无昵称), createdTime=Thu Dec 05 15:44:35 CST 2024, time=2024-12-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2239680, encodeId=4f5c22396803b, content=对这个期刊大无语，提了一个比较新颖的观点，三个审稿人两轮审稿前后六个月时间，最后审稿人没问题了，编辑不认同我文章提出的主要观点，给拒了，你早干嘛去了啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4579315575, createdName=ms2000001369168749, createdTime=Thu Nov 28 09:47:05 CST 2024, time=2024-11-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2240722, encodeId=a9962240e2254, content=投稿命中率:25.0 经验分享：投稿第七天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c8f9557053, createdName=ms2000001959141443, createdTime=Tue Dec 03 23:49:38 CST 2024, time=2024-12-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200944, encodeId=4a382200944df, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：拒稿挺干脆的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96539239417, createdName=ms3000001172034074, createdTime=Sun Apr 28 21:31:39 CST 2024, time=2024-04-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155573, encodeId=79fc21555e3e3, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：阿尔茨海默;脑血管病 经验分享：BMC Medicine，BMC家旗下相当好的综合医学期刊，当前(指截止2023.9.1) Impact Factor 9.3，但是审稿速度相当堪忧，官网提供的宣称指出“62 days submission to first editorial decision for all manuscripts (Median)，130 days submission to accept (Median)”，即中位数62天才能给出第一次送外审后的编辑部决定，中位数130天才能正式接受发表。但实际上其官网的Transparent Peer Review指出大部分稿件往往需要花上近半年的时间才可以最终发表，并且审稿人中途退出以及更换审稿人的现象较为常见，审稿人以及编辑部的意见也往往较为犀利，Submission多需要经过三四次的Revision才会被最终Accept，综合评价为投递需要经过慎重考虑，Desk Reject那便还好，如果你的文章时效性较强，那么一旦被送出外审后进入漫长的Review恐会影响你文章后续的时效性价值，甚至有被其他课题研究人员于某些****杂志抢发类似文章的风险, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Fri Sep 01 09:54:24 CST 2023, time=2023-09-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191029, encodeId=68a12191029fd, content=1-6 投稿 1-6 editor assigned 1-11 reviewers assigned 2-27 under review 3-1 reviewers assigned 3-3 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a18637611, createdName=ms3000001077948666, createdTime=Mon Mar 04 19:27:41 CST 2024, time=2024-03-04, status=1, ipAttribution=北京)]

2024-11-26 ms9000001244919142 来自广东省

审稿速度:6.0
经验分享：7.25提交投稿，9.13审稿意见回来要求大修，10.3提交修订版，10.25系统显示编辑已收到全部审稿意见，然而过了一个月多没消息了，发了催稿信也没回复，不知道编辑什么决定~~~

120 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2242072, encodeId=3adc22420e28d, content=10月份投稿，11月审稿意见大修，12月返修，目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b482175865, createdName=12060c54m83(暂无昵称), createdTime=Thu Dec 12 16:21:06 CST 2024, time=2024-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2243718, encodeId=5adf2243e182c, content=偏重的研究方向：流行病学 经验分享：今年12月4日投稿BMC medicine，投稿当天到现在12月20日还是with editor状况，是我太急了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b9c6398102, createdName=ms3000001290442795, createdTime=Fri Dec 20 11:08:01 CST 2024, time=2024-12-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2239220, encodeId=3100223922047, content=第二次外审意见回来后在编辑那里1个多月了也没信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Nov 26 10:28:34 CST 2024, time=2024-11-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2239217, encodeId=b116223921ed0, content=审稿速度:6.0 经验分享：7.25提交投稿，9.13审稿意见回来要求大修，10.3提交修订版，10.25系统显示编辑已收到全部审稿意见，然而过了一个月多没消息了，发了催稿信也没回复，不知道编辑什么决定~~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Nov 26 10:17:56 CST 2024, time=2024-11-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2240967, encodeId=9ca3224096e4d, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审2个月，半个月回复，目前分配编辑状态半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b482175865, createdName=12060c54m83(暂无昵称), createdTime=Thu Dec 05 15:44:35 CST 2024, time=2024-12-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2239680, encodeId=4f5c22396803b, content=对这个期刊大无语，提了一个比较新颖的观点，三个审稿人两轮审稿前后六个月时间，最后审稿人没问题了，编辑不认同我文章提出的主要观点，给拒了，你早干嘛去了啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4579315575, createdName=ms2000001369168749, createdTime=Thu Nov 28 09:47:05 CST 2024, time=2024-11-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2240722, encodeId=a9962240e2254, content=投稿命中率:25.0 经验分享：投稿第七天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c8f9557053, createdName=ms2000001959141443, createdTime=Tue Dec 03 23:49:38 CST 2024, time=2024-12-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200944, encodeId=4a382200944df, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：拒稿挺干脆的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96539239417, createdName=ms3000001172034074, createdTime=Sun Apr 28 21:31:39 CST 2024, time=2024-04-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155573, encodeId=79fc21555e3e3, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：阿尔茨海默;脑血管病 经验分享：BMC Medicine，BMC家旗下相当好的综合医学期刊，当前(指截止2023.9.1) Impact Factor 9.3，但是审稿速度相当堪忧，官网提供的宣称指出“62 days submission to first editorial decision for all manuscripts (Median)，130 days submission to accept (Median)”，即中位数62天才能给出第一次送外审后的编辑部决定，中位数130天才能正式接受发表。但实际上其官网的Transparent Peer Review指出大部分稿件往往需要花上近半年的时间才可以最终发表，并且审稿人中途退出以及更换审稿人的现象较为常见，审稿人以及编辑部的意见也往往较为犀利，Submission多需要经过三四次的Revision才会被最终Accept，综合评价为投递需要经过慎重考虑，Desk Reject那便还好，如果你的文章时效性较强，那么一旦被送出外审后进入漫长的Review恐会影响你文章后续的时效性价值，甚至有被其他课题研究人员于某些****杂志抢发类似文章的风险, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Fri Sep 01 09:54:24 CST 2023, time=2023-09-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191029, encodeId=68a12191029fd, content=1-6 投稿 1-6 editor assigned 1-11 reviewers assigned 2-27 under review 3-1 reviewers assigned 3-3 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a18637611, createdName=ms3000001077948666, createdTime=Mon Mar 04 19:27:41 CST 2024, time=2024-03-04, status=1, ipAttribution=北京)]

2024-12-05 12060c54m83(暂无昵称) 来自四川省

审稿速度:6.0 | 投稿命中率:25.0
经验分享：一审2个月，半个月回复，目前分配编辑状态半个月。

17 0

[GetPortalCommentsPageByObjectIdResponse(id=2242072, encodeId=3adc22420e28d, content=10月份投稿，11月审稿意见大修，12月返修，目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b482175865, createdName=12060c54m83(暂无昵称), createdTime=Thu Dec 12 16:21:06 CST 2024, time=2024-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2243718, encodeId=5adf2243e182c, content=偏重的研究方向：流行病学 经验分享：今年12月4日投稿BMC medicine，投稿当天到现在12月20日还是with editor状况，是我太急了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b9c6398102, createdName=ms3000001290442795, createdTime=Fri Dec 20 11:08:01 CST 2024, time=2024-12-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2239220, encodeId=3100223922047, content=第二次外审意见回来后在编辑那里1个多月了也没信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Nov 26 10:28:34 CST 2024, time=2024-11-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2239217, encodeId=b116223921ed0, content=审稿速度:6.0 经验分享：7.25提交投稿，9.13审稿意见回来要求大修，10.3提交修订版，10.25系统显示编辑已收到全部审稿意见，然而过了一个月多没消息了，发了催稿信也没回复，不知道编辑什么决定~~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Nov 26 10:17:56 CST 2024, time=2024-11-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2240967, encodeId=9ca3224096e4d, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审2个月，半个月回复，目前分配编辑状态半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b482175865, createdName=12060c54m83(暂无昵称), createdTime=Thu Dec 05 15:44:35 CST 2024, time=2024-12-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2239680, encodeId=4f5c22396803b, content=对这个期刊大无语，提了一个比较新颖的观点，三个审稿人两轮审稿前后六个月时间，最后审稿人没问题了，编辑不认同我文章提出的主要观点，给拒了，你早干嘛去了啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4579315575, createdName=ms2000001369168749, createdTime=Thu Nov 28 09:47:05 CST 2024, time=2024-11-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2240722, encodeId=a9962240e2254, content=投稿命中率:25.0 经验分享：投稿第七天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c8f9557053, createdName=ms2000001959141443, createdTime=Tue Dec 03 23:49:38 CST 2024, time=2024-12-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200944, encodeId=4a382200944df, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：拒稿挺干脆的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96539239417, createdName=ms3000001172034074, createdTime=Sun Apr 28 21:31:39 CST 2024, time=2024-04-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155573, encodeId=79fc21555e3e3, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：阿尔茨海默;脑血管病 经验分享：BMC Medicine，BMC家旗下相当好的综合医学期刊，当前(指截止2023.9.1) Impact Factor 9.3，但是审稿速度相当堪忧，官网提供的宣称指出“62 days submission to first editorial decision for all manuscripts (Median)，130 days submission to accept (Median)”，即中位数62天才能给出第一次送外审后的编辑部决定，中位数130天才能正式接受发表。但实际上其官网的Transparent Peer Review指出大部分稿件往往需要花上近半年的时间才可以最终发表，并且审稿人中途退出以及更换审稿人的现象较为常见，审稿人以及编辑部的意见也往往较为犀利，Submission多需要经过三四次的Revision才会被最终Accept，综合评价为投递需要经过慎重考虑，Desk Reject那便还好，如果你的文章时效性较强，那么一旦被送出外审后进入漫长的Review恐会影响你文章后续的时效性价值，甚至有被其他课题研究人员于某些****杂志抢发类似文章的风险, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Fri Sep 01 09:54:24 CST 2023, time=2023-09-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191029, encodeId=68a12191029fd, content=1-6 投稿 1-6 editor assigned 1-11 reviewers assigned 2-27 under review 3-1 reviewers assigned 3-3 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a18637611, createdName=ms3000001077948666, createdTime=Mon Mar 04 19:27:41 CST 2024, time=2024-03-04, status=1, ipAttribution=北京)]

2024-11-28 ms2000001369168749 来自吉林省

对这个期刊大无语，提了一个比较新颖的观点，三个审稿人两轮审稿前后六个月时间，最后审稿人没问题了，编辑不认同我文章提出的主要观点，给拒了，你早干嘛去了啊？

23 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2242072, encodeId=3adc22420e28d, content=10月份投稿，11月审稿意见大修，12月返修，目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b482175865, createdName=12060c54m83(暂无昵称), createdTime=Thu Dec 12 16:21:06 CST 2024, time=2024-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2243718, encodeId=5adf2243e182c, content=偏重的研究方向：流行病学 经验分享：今年12月4日投稿BMC medicine，投稿当天到现在12月20日还是with editor状况，是我太急了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b9c6398102, createdName=ms3000001290442795, createdTime=Fri Dec 20 11:08:01 CST 2024, time=2024-12-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2239220, encodeId=3100223922047, content=第二次外审意见回来后在编辑那里1个多月了也没信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Nov 26 10:28:34 CST 2024, time=2024-11-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2239217, encodeId=b116223921ed0, content=审稿速度:6.0 经验分享：7.25提交投稿，9.13审稿意见回来要求大修，10.3提交修订版，10.25系统显示编辑已收到全部审稿意见，然而过了一个月多没消息了，发了催稿信也没回复，不知道编辑什么决定~~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Nov 26 10:17:56 CST 2024, time=2024-11-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2240967, encodeId=9ca3224096e4d, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审2个月，半个月回复，目前分配编辑状态半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b482175865, createdName=12060c54m83(暂无昵称), createdTime=Thu Dec 05 15:44:35 CST 2024, time=2024-12-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2239680, encodeId=4f5c22396803b, content=对这个期刊大无语，提了一个比较新颖的观点，三个审稿人两轮审稿前后六个月时间，最后审稿人没问题了，编辑不认同我文章提出的主要观点，给拒了，你早干嘛去了啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4579315575, createdName=ms2000001369168749, createdTime=Thu Nov 28 09:47:05 CST 2024, time=2024-11-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2240722, encodeId=a9962240e2254, content=投稿命中率:25.0 经验分享：投稿第七天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c8f9557053, createdName=ms2000001959141443, createdTime=Tue Dec 03 23:49:38 CST 2024, time=2024-12-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200944, encodeId=4a382200944df, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：拒稿挺干脆的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96539239417, createdName=ms3000001172034074, createdTime=Sun Apr 28 21:31:39 CST 2024, time=2024-04-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155573, encodeId=79fc21555e3e3, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：阿尔茨海默;脑血管病 经验分享：BMC Medicine，BMC家旗下相当好的综合医学期刊，当前(指截止2023.9.1) Impact Factor 9.3，但是审稿速度相当堪忧，官网提供的宣称指出“62 days submission to first editorial decision for all manuscripts (Median)，130 days submission to accept (Median)”，即中位数62天才能给出第一次送外审后的编辑部决定，中位数130天才能正式接受发表。但实际上其官网的Transparent Peer Review指出大部分稿件往往需要花上近半年的时间才可以最终发表，并且审稿人中途退出以及更换审稿人的现象较为常见，审稿人以及编辑部的意见也往往较为犀利，Submission多需要经过三四次的Revision才会被最终Accept，综合评价为投递需要经过慎重考虑，Desk Reject那便还好，如果你的文章时效性较强，那么一旦被送出外审后进入漫长的Review恐会影响你文章后续的时效性价值，甚至有被其他课题研究人员于某些****杂志抢发类似文章的风险, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Fri Sep 01 09:54:24 CST 2023, time=2023-09-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191029, encodeId=68a12191029fd, content=1-6 投稿 1-6 editor assigned 1-11 reviewers assigned 2-27 under review 3-1 reviewers assigned 3-3 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a18637611, createdName=ms3000001077948666, createdTime=Mon Mar 04 19:27:41 CST 2024, time=2024-03-04, status=1, ipAttribution=北京)]

2024-12-03 ms2000001959141443 来自北京

投稿命中率:25.0
经验分享：投稿第七天被拒

23 0

[GetPortalCommentsPageByObjectIdResponse(id=2242072, encodeId=3adc22420e28d, content=10月份投稿，11月审稿意见大修，12月返修，目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b482175865, createdName=12060c54m83(暂无昵称), createdTime=Thu Dec 12 16:21:06 CST 2024, time=2024-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2243718, encodeId=5adf2243e182c, content=偏重的研究方向：流行病学 经验分享：今年12月4日投稿BMC medicine，投稿当天到现在12月20日还是with editor状况，是我太急了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b9c6398102, createdName=ms3000001290442795, createdTime=Fri Dec 20 11:08:01 CST 2024, time=2024-12-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2239220, encodeId=3100223922047, content=第二次外审意见回来后在编辑那里1个多月了也没信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Nov 26 10:28:34 CST 2024, time=2024-11-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2239217, encodeId=b116223921ed0, content=审稿速度:6.0 经验分享：7.25提交投稿，9.13审稿意见回来要求大修，10.3提交修订版，10.25系统显示编辑已收到全部审稿意见，然而过了一个月多没消息了，发了催稿信也没回复，不知道编辑什么决定~~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Nov 26 10:17:56 CST 2024, time=2024-11-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2240967, encodeId=9ca3224096e4d, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审2个月，半个月回复，目前分配编辑状态半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b482175865, createdName=12060c54m83(暂无昵称), createdTime=Thu Dec 05 15:44:35 CST 2024, time=2024-12-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2239680, encodeId=4f5c22396803b, content=对这个期刊大无语，提了一个比较新颖的观点，三个审稿人两轮审稿前后六个月时间，最后审稿人没问题了，编辑不认同我文章提出的主要观点，给拒了，你早干嘛去了啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4579315575, createdName=ms2000001369168749, createdTime=Thu Nov 28 09:47:05 CST 2024, time=2024-11-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2240722, encodeId=a9962240e2254, content=投稿命中率:25.0 经验分享：投稿第七天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c8f9557053, createdName=ms2000001959141443, createdTime=Tue Dec 03 23:49:38 CST 2024, time=2024-12-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200944, encodeId=4a382200944df, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：拒稿挺干脆的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96539239417, createdName=ms3000001172034074, createdTime=Sun Apr 28 21:31:39 CST 2024, time=2024-04-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155573, encodeId=79fc21555e3e3, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：阿尔茨海默;脑血管病 经验分享：BMC Medicine，BMC家旗下相当好的综合医学期刊，当前(指截止2023.9.1) Impact Factor 9.3，但是审稿速度相当堪忧，官网提供的宣称指出“62 days submission to first editorial decision for all manuscripts (Median)，130 days submission to accept (Median)”，即中位数62天才能给出第一次送外审后的编辑部决定，中位数130天才能正式接受发表。但实际上其官网的Transparent Peer Review指出大部分稿件往往需要花上近半年的时间才可以最终发表，并且审稿人中途退出以及更换审稿人的现象较为常见，审稿人以及编辑部的意见也往往较为犀利，Submission多需要经过三四次的Revision才会被最终Accept，综合评价为投递需要经过慎重考虑，Desk Reject那便还好，如果你的文章时效性较强，那么一旦被送出外审后进入漫长的Review恐会影响你文章后续的时效性价值，甚至有被其他课题研究人员于某些****杂志抢发类似文章的风险, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Fri Sep 01 09:54:24 CST 2023, time=2023-09-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191029, encodeId=68a12191029fd, content=1-6 投稿 1-6 editor assigned 1-11 reviewers assigned 2-27 under review 3-1 reviewers assigned 3-3 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a18637611, createdName=ms3000001077948666, createdTime=Mon Mar 04 19:27:41 CST 2024, time=2024-03-04, status=1, ipAttribution=北京)]

2024-04-28 ms3000001172034074 来自湖南省

审稿速度:1.0 | 投稿命中率:25.0
经验分享：拒稿挺干脆的

266 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2242072, encodeId=3adc22420e28d, content=10月份投稿，11月审稿意见大修，12月返修，目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b482175865, createdName=12060c54m83(暂无昵称), createdTime=Thu Dec 12 16:21:06 CST 2024, time=2024-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2243718, encodeId=5adf2243e182c, content=偏重的研究方向：流行病学 经验分享：今年12月4日投稿BMC medicine，投稿当天到现在12月20日还是with editor状况，是我太急了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b9c6398102, createdName=ms3000001290442795, createdTime=Fri Dec 20 11:08:01 CST 2024, time=2024-12-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2239220, encodeId=3100223922047, content=第二次外审意见回来后在编辑那里1个多月了也没信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Nov 26 10:28:34 CST 2024, time=2024-11-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2239217, encodeId=b116223921ed0, content=审稿速度:6.0 经验分享：7.25提交投稿，9.13审稿意见回来要求大修，10.3提交修订版，10.25系统显示编辑已收到全部审稿意见，然而过了一个月多没消息了，发了催稿信也没回复，不知道编辑什么决定~~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Nov 26 10:17:56 CST 2024, time=2024-11-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2240967, encodeId=9ca3224096e4d, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审2个月，半个月回复，目前分配编辑状态半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b482175865, createdName=12060c54m83(暂无昵称), createdTime=Thu Dec 05 15:44:35 CST 2024, time=2024-12-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2239680, encodeId=4f5c22396803b, content=对这个期刊大无语，提了一个比较新颖的观点，三个审稿人两轮审稿前后六个月时间，最后审稿人没问题了，编辑不认同我文章提出的主要观点，给拒了，你早干嘛去了啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4579315575, createdName=ms2000001369168749, createdTime=Thu Nov 28 09:47:05 CST 2024, time=2024-11-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2240722, encodeId=a9962240e2254, content=投稿命中率:25.0 经验分享：投稿第七天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c8f9557053, createdName=ms2000001959141443, createdTime=Tue Dec 03 23:49:38 CST 2024, time=2024-12-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200944, encodeId=4a382200944df, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：拒稿挺干脆的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96539239417, createdName=ms3000001172034074, createdTime=Sun Apr 28 21:31:39 CST 2024, time=2024-04-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155573, encodeId=79fc21555e3e3, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：阿尔茨海默;脑血管病 经验分享：BMC Medicine，BMC家旗下相当好的综合医学期刊，当前(指截止2023.9.1) Impact Factor 9.3，但是审稿速度相当堪忧，官网提供的宣称指出“62 days submission to first editorial decision for all manuscripts (Median)，130 days submission to accept (Median)”，即中位数62天才能给出第一次送外审后的编辑部决定，中位数130天才能正式接受发表。但实际上其官网的Transparent Peer Review指出大部分稿件往往需要花上近半年的时间才可以最终发表，并且审稿人中途退出以及更换审稿人的现象较为常见，审稿人以及编辑部的意见也往往较为犀利，Submission多需要经过三四次的Revision才会被最终Accept，综合评价为投递需要经过慎重考虑，Desk Reject那便还好，如果你的文章时效性较强，那么一旦被送出外审后进入漫长的Review恐会影响你文章后续的时效性价值，甚至有被其他课题研究人员于某些****杂志抢发类似文章的风险, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Fri Sep 01 09:54:24 CST 2023, time=2023-09-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191029, encodeId=68a12191029fd, content=1-6 投稿 1-6 editor assigned 1-11 reviewers assigned 2-27 under review 3-1 reviewers assigned 3-3 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a18637611, createdName=ms3000001077948666, createdTime=Mon Mar 04 19:27:41 CST 2024, time=2024-03-04, status=1, ipAttribution=北京)]

2023-09-01 ms5000000540226119 来自江苏省

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：阿尔茨海默;脑血管病
经验分享：BMC Medicine，BMC家旗下相当好的综合医学期刊，当前(指截止2023.9.1) Impact Factor 9.3，但是审稿速度相当堪忧，官网提供的宣称指出“62 days submission to first editorial decision for all manuscripts (Median)，130 days submission to accept (Median)”，即中位数62天才能给出第一次送外审后的编辑部决定，中位数130天才能正式接受发表。但实际上其官网的Transparent Peer Review指出大部分稿件往往需要花上近半年的时间才可以最终发表，并且审稿人中途退出以及更换审稿人的现象较为常见，审稿人以及编辑部的意见也往往较为犀利，Submission多需要经过三四次的Revision才会被最终Accept，综合评价为投递需要经过慎重考虑，Desk Reject那便还好，如果你的文章时效性较强，那么一旦被送出外审后进入漫长的Review恐会影响你文章后续的时效性价值，甚至有被其他课题研究人员于某些****杂志抢发类似文章的风险

346 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2242072, encodeId=3adc22420e28d, content=10月份投稿，11月审稿意见大修，12月返修，目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b482175865, createdName=12060c54m83(暂无昵称), createdTime=Thu Dec 12 16:21:06 CST 2024, time=2024-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2243718, encodeId=5adf2243e182c, content=偏重的研究方向：流行病学 经验分享：今年12月4日投稿BMC medicine，投稿当天到现在12月20日还是with editor状况，是我太急了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b9c6398102, createdName=ms3000001290442795, createdTime=Fri Dec 20 11:08:01 CST 2024, time=2024-12-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2239220, encodeId=3100223922047, content=第二次外审意见回来后在编辑那里1个多月了也没信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Nov 26 10:28:34 CST 2024, time=2024-11-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2239217, encodeId=b116223921ed0, content=审稿速度:6.0 经验分享：7.25提交投稿，9.13审稿意见回来要求大修，10.3提交修订版，10.25系统显示编辑已收到全部审稿意见，然而过了一个月多没消息了，发了催稿信也没回复，不知道编辑什么决定~~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=945f9328796, createdName=ms9000001244919142, createdTime=Tue Nov 26 10:17:56 CST 2024, time=2024-11-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2240967, encodeId=9ca3224096e4d, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：一审2个月，半个月回复，目前分配编辑状态半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b482175865, createdName=12060c54m83(暂无昵称), createdTime=Thu Dec 05 15:44:35 CST 2024, time=2024-12-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2239680, encodeId=4f5c22396803b, content=对这个期刊大无语，提了一个比较新颖的观点，三个审稿人两轮审稿前后六个月时间，最后审稿人没问题了，编辑不认同我文章提出的主要观点，给拒了，你早干嘛去了啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4579315575, createdName=ms2000001369168749, createdTime=Thu Nov 28 09:47:05 CST 2024, time=2024-11-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2240722, encodeId=a9962240e2254, content=投稿命中率:25.0 经验分享：投稿第七天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c8f9557053, createdName=ms2000001959141443, createdTime=Tue Dec 03 23:49:38 CST 2024, time=2024-12-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200944, encodeId=4a382200944df, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：拒稿挺干脆的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96539239417, createdName=ms3000001172034074, createdTime=Sun Apr 28 21:31:39 CST 2024, time=2024-04-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155573, encodeId=79fc21555e3e3, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：阿尔茨海默;脑血管病 经验分享：BMC Medicine，BMC家旗下相当好的综合医学期刊，当前(指截止2023.9.1) Impact Factor 9.3，但是审稿速度相当堪忧，官网提供的宣称指出“62 days submission to first editorial decision for all manuscripts (Median)，130 days submission to accept (Median)”，即中位数62天才能给出第一次送外审后的编辑部决定，中位数130天才能正式接受发表。但实际上其官网的Transparent Peer Review指出大部分稿件往往需要花上近半年的时间才可以最终发表，并且审稿人中途退出以及更换审稿人的现象较为常见，审稿人以及编辑部的意见也往往较为犀利，Submission多需要经过三四次的Revision才会被最终Accept，综合评价为投递需要经过慎重考虑，Desk Reject那便还好，如果你的文章时效性较强，那么一旦被送出外审后进入漫长的Review恐会影响你文章后续的时效性价值，甚至有被其他课题研究人员于某些****杂志抢发类似文章的风险, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Fri Sep 01 09:54:24 CST 2023, time=2023-09-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191029, encodeId=68a12191029fd, content=1-6 投稿 1-6 editor assigned 1-11 reviewers assigned 2-27 under review 3-1 reviewers assigned 3-3 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=368, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a18637611, createdName=ms3000001077948666, createdTime=Mon Mar 04 19:27:41 CST 2024, time=2024-03-04, status=1, ipAttribution=北京)]

2024-03-04 ms3000001077948666 来自北京

1-6 投稿
1-6 editor assigned
1-11 reviewers assigned
2-27 under review
3-1 reviewers assigned
3-3 under review

368 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务